the corporate reputation of pharma the … · the corporate reputation of pharma —the patient...
TRANSCRIPT
Feedback from 797 patient groups in Europe PUBLISHED APRIL 2016
THE CORPORATE REPUTATION OF PHARMA —THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION)
“The perception [of pharma] has changed in the last years, associating more to research.” —National patient group in Spain specialising in mental health
in 2016, patientview is publishing 20 ‘corporate reputation of pharma’ reports, analysing the results from the 1,075 patient groups responding to the 2015 survey.
speciality reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports)
geographic-region reports (in addition to this current europe report): eastern europe I germany I global I italy I latin america I nordic I spain I uk I usa (10 reports)
CONTENTS
ABOUT THIS REPORT Page 1
WHAT DID PATIENT GROUPS IN EUROPE SAY ABOUT PHARMA IN 2015?
Summary of the industry-wide finding in Europe Page 3
A FEW COMMENTS ON THE EUROPEAN CORPORATE RANKINGS Page 5
WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE
REPUTATION? Page 6
COMMENTS FROM PATIENT GROUPS IN EUROPE, 2015 Page 7
CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT ...
AbbVie Eisai Janssen EMEA (pharmaceutical companies of Johnson & Johnson) Sanofi
Page 16 Page 18 Page 21 Page 24
METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 27
QUESTIONNAIRE FOR PHARMA COMPANIES 2015 Page 28
APPENDIX 1:
Data on how patient groups in Europe see the pharmaceutical industry in 2015,
and in 2014
Page 29
APPENDIX 2:
Rankings of the 45 pharma companies for each of the 6 indicators of corporate
reputation, as perceived by patient groups in Europe in 2015, compared with 2014
Page 34
APPENDIX 3:
Profiles of the 45 companies Page 43
APPENDIX 4:
Profiles of the 797 respondent patient groups Page 90
Percentage of patient groups in Europe claiming familiarity with the company Page 2
Percentage of patient groups in Europe claiming familiarity, and which also worked with the company Page 2
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at fair pricing Page 4
Rising stars in Europe 2015 (companies that have risen up the ranks 2015 v 2014, or lead the ranks in 2015) Page 5
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
Page 6
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
Page 30
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the pharma industry in 2015?
Page 30
What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 31
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
Page 32
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? (Year-on-year comparators: Europe 2015, Europe 2014, and global 2015)
Page 33
Companies with the most effective patient-centred strategy (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Page 35
Companies providing the best high-quality patient information (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Page 36
Companies with the best record on patient safety (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Page 37
Companies with the most-useful high-quality products (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Page 38
Companies with the best record of transparency (rankings of 45 companies, 2015; rankings of 34 companies, 2014)
Page 39
Companies with the best record on integrity (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Page 40
Rankings of the 45 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 41
Rankings of the 45 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 42
LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF PATIENT GROUPS IN EUROPE
LIST OF TABLES AND CHARTS – CONTINUED
AbbVie page 45
Actavis page 46
Allergan page 47
Almirall page 48
Amgen page 49
Astellas page 50
AstraZeneca page 51
Baxalta page 52
Bayer page 53
Biogen Idec page 54
Boehringer Ingelheim page 55
B-MS page 56
Celgene page 57
Chiesi page 58
Eisai page 59
Eli Lilly page 60
Ferring page 61
Gedeon Richter page 62
Gilead Sciences page 63
Grünenthal page 64
GSK page 65
Hospira page 66
Ipsen page 67
Janssen page 68
LEO Pharma page 69
Lundbeck page 70
Menarini page 71
Merck & Co (US) page 72
Merck KGaA (Germany) page 73
Mylan page 74
Novartis page 75
Novo Nordisk page 76
Octapharma page 77
Otsuka page 78
Pfizer page 79
Roche page 80
Sandoz page 81
Sanofi page 82
Servier page 83
Shire page 84
Stada Arzneimittel page 85
Takeda page 86
Teva page 87
UCB page 88
ViiV Healthcare page 89
profiles of the 45 companies, according to the
patient groups in europe familiar with these
companies or have worked with them
Each profile contains ...
company background information
Annual revenue (latest-available year), comprising amount in
currency, as quoted by the profiled company itself. ↑ = increase
in revenue over the previous year –or– ↓= decrease in revenue.
The profiled company’s main treatment subject areas (and areas
of R&D).
A mission statement from the profiled company.
how the company has performed at six indicators of
corporate reputation
The profiled company’s performance at the six indicators of
corporate reputation in 2015, according to the patient groups in
Europe familiar with the company.
The profiled company’s performance at the six indicators of
corporate reputation, according to the patient groups in Europe
that have worked with the company.
How the profiled company performed in Europe for different
therapy areas, compared with the company’s averages in Europe
across all therapy areas in 2015.
How the profiled company performed in Europe for different
countries/regions, compared with the company’s averages in
Europe in 2015.
how the company ranks for corporate reputation
compared with other companies
The profiled company’s rankings in Europe in 2015 for the six
indicators of corporate reputation, compared with 44 other
companies
The profiled company’s rankings worldwide in 2015 for the six
indicators of corporate reputation, compared with 44 other
companies
profile of the patient groups familiar with the company
Other companies that partner with a significant number of the
profiled company’s partner patient groups.
The therapy areas and countries of the patient groups familiar
with the profiled company.
Janssen Pharmaceutical Companies of Johnson & Johnson
Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0)1547-520-965 E-mail: [email protected] Registered in England, number: 3944382 Data protection registration number: Z7133076 VAT registration number: GB-760-985-885
Copyright © 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.